Download 23. Frenkel lecture: FMD vaccine development - past and future

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Monoclonal antibody wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Immunocontraception wikipedia , lookup

Lymphopoiesis wikipedia , lookup

Duffy antigen system wikipedia , lookup

Phagocyte wikipedia , lookup

Vaccination wikipedia , lookup

Henipavirus wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Immune system wikipedia , lookup

T cell wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Hepatitis B wikipedia , lookup

DNA vaccination wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Innate immune system wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Adaptive immune system wikipedia , lookup

Adoptive cell transfer wikipedia , lookup

Molecular mimicry wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Immunomics wikipedia , lookup

Transcript
The Global control of FMD - Tools, ideas and ideals – Erice, Italy 14-17 October 2008
Appendix 23
FRENKEL LECTURE: FMD VACCINE DEVELOPMENT - PAST AND FUTURE
L. Robinson1, M. Windsor, J. Hope1, G. MacPherson2, B. Charleston1*
2
1
Institute for Animal Health, Pirbright Laboratory, Guildford GU24 0NF.
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE.
INTRODUCTION
Foot-and-mouth Disease Virus (FMDV) causes a highly contagious acute vesicular disease affecting
a number of economically important animal species. Little is known about the interaction of the
virus with cattle dendritic cells (DC). Development of a comprehensive protective T and B cell
response requires antigen capture, migration, maturation and antigen presentation by DCs. The
capacity to stimulate CD8 and CD4 T cells relies upon the presentation of antigen through MHC
class I and II molecules respectively. There is stimulation of specific CD4 and CD8 responses to live
and killed FMDV antigen, suggesting presentation occurs through the class I and II pathways.
However, the response of CD4 and CD8 T cells isolated from infected cattle are consistently low
compared to the response to control antigens, despite the absence of generalised
immunosuppression in the FMDV infected cattle. The specific CD4 response to vaccination is
variable.
MATERIAL AND METHODS
Bovine dendritic cells generated from CD14+ monocytes were (MoDC) were produced by published
methods. Experiments were performed to determine integrin expression on these cells and whether
serotype O FMDV could productively infect these cells. In addition, the effect of adding immune
complexed virus to the DC was studied. Furthermore, the capacity of DC, pulsed with virus or
inactivated antigen, to stimulate specific CD4+ T cell proliferation was determined.
RESULTS
MoDC do not express the integrin used by FMDV for entry and non-structural proteins are detected
in 5% of the cells by flow cytometry. In contrast, 70% of the MoDC are infected after the addition
of immune complexed virus, causing cell death in 6-8 hours, the production of type-I interferons
and decreasing the ability to stimulate specific CD4+ T-cell proliferation.
Using immune complexed inactivated virus to target uptake by MoDC, resulted in enhanced CD4+
T-cell proliferation.
DISCUSSION
These in vitro observations improve our understanding of the development of the immune response
to FMDV infection in vivo and suggest alternative strategies to improve vaccine efficacy.
157
The Global control of FMD - Tools, ideas and ideals – Erice, Italy 14-17 October 2008
158